UniProt ID | FETUA_HUMAN | |
---|---|---|
UniProt AC | P02765 | |
Protein Name | Alpha-2-HS-glycoprotein | |
Gene Name | AHSG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 367 | |
Subcellular Localization | Secreted. | |
Protein Description | Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions.. | |
Protein Sequence | MKSLVLLLCLAQLWGCHSAPHGPGLIYRQPNCDDPETEEAALVAIDYINQNLPWGYKHTLNQIDEVKVWPQQPSGELFEIEIDTLETTCHVLDPTPVARCSVRQLKEHAVEGDCDFQLLKLDGKFSVVYAKCDSSPDSAEDVRKVCQDCPLLAPLNDTRVVHAAKAALAAFNAQNNGSNFQLEEISRAQLVPLPPSTYVEFTVSGTDCVAKEATEAAKCNLLAEKQYGFCKATLSEKLGGAEVAVTCTVFQTQPVTSQPQPEGANEAVPTPVVDPDAPPSPPLGAPGLPPAGSPPDSHVLLAAPPGHQLHRAHYDLRHTFMGVVSLGSPSGEVSHPRKTRTVVQPSVGAAAGPVVPPCPGRIRHFKV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
59 | O-linked_Glycosylation | LPWGYKHTLNQIDEV CCCCCCCCCCCCCEE | 24.21 | OGP | |
59 | Phosphorylation | LPWGYKHTLNQIDEV CCCCCCCCCCCCCEE | 24.21 | 24144214 | |
74 | Phosphorylation | KVWPQQPSGELFEIE EECCCCCCCCEEEEE | 40.33 | 27130503 | |
124 | Acetylation | QLLKLDGKFSVVYAK EEEEECCEEEEEEEE | 33.85 | 27178108 | |
126 | Phosphorylation | LKLDGKFSVVYAKCD EEECCEEEEEEEECC | 17.73 | 29759185 | |
129 | Phosphorylation | DGKFSVVYAKCDSSP CCEEEEEEEECCCCC | 9.74 | 29759185 | |
131 | Ubiquitination | KFSVVYAKCDSSPDS EEEEEEEECCCCCCC | 22.38 | - | |
134 | Phosphorylation | VVYAKCDSSPDSAED EEEEECCCCCCCHHH | 53.92 | 24043423 | |
135 | Phosphorylation | VYAKCDSSPDSAEDV EEEECCCCCCCHHHH | 21.34 | 23911959 | |
137 | Phosphorylation | AKCDSSPDSAEDVRK EECCCCCCCHHHHHH | 63.53 | 32645325 | |
138 | Phosphorylation | KCDSSPDSAEDVRKV ECCCCCCCHHHHHHH | 36.62 | 19664994 | |
144 | Acetylation | DSAEDVRKVCQDCPL CCHHHHHHHHHCCCC | 47.40 | 129503 | |
156 | N-linked_Glycosylation | CPLLAPLNDTRVVHA CCCEEECCCCHHHHH | 47.77 | 22171320 | |
156 | N-linked_Glycosylation | CPLLAPLNDTRVVHA CCCEEECCCCHHHHH | 47.77 | 22171320 | |
176 | N-linked_Glycosylation | AAFNAQNNGSNFQLE HHHHHCCCCCCCCCE | 43.09 | 22171320 | |
176 | N-linked_Glycosylation | AAFNAQNNGSNFQLE HHHHHCCCCCCCCCE | 43.09 | 22171320 | |
196 | O-linked_Glycosylation | QLVPLPPSTYVEFTV EEECCCCCCEEEEEE | 30.36 | OGP | |
197 | O-linked_Glycosylation | LVPLPPSTYVEFTVS EECCCCCCEEEEEEE | 37.04 | OGP | |
202 | O-linked_Glycosylation | PSTYVEFTVSGTDCV CCCEEEEEEECCCHH | 10.56 | OGP | |
224 | Ubiquitination | AKCNLLAEKQYGFCK HHCCHHHHHHHCCCE | 40.43 | 33845483 | |
225 | Acetylation | KCNLLAEKQYGFCKA HCCHHHHHHHCCCEE | 43.12 | 26051181 | |
225 | Ubiquitination | KCNLLAEKQYGFCKA HCCHHHHHHHCCCEE | 43.12 | 33845483 | |
227 | Phosphorylation | NLLAEKQYGFCKATL CHHHHHHHCCCEEHH | 24.20 | - | |
231 | Methylation | EKQYGFCKATLSEKL HHHHCCCEEHHHHHH | 41.99 | - | |
256 | O-linked_Glycosylation | VFQTQPVTSQPQPEG EEECCCCCCCCCCCC | 28.47 | 6833285 | |
270 | O-linked_Glycosylation | GANEAVPTPVVDPDA CCCCCCCCCCCCCCC | 23.32 | 6833285 | |
270 | O-linked_Glycosylation | GANEAVPTPVVDPDA CCCCCCCCCCCCCCC | 23.32 | 3944104 | |
280 | O-linked_Glycosylation | VDPDAPPSPPLGAPG CCCCCCCCCCCCCCC | 37.78 | OGP | |
293 | O-linked_Glycosylation | PGLPPAGSPPDSHVL CCCCCCCCCCCCEEE | 35.05 | OGP | |
319 | Phosphorylation | AHYDLRHTFMGVVSL EECCHHHHEEEEEEC | 14.64 | 28060719 | |
319 | O-linked_Glycosylation | AHYDLRHTFMGVVSL EECCHHHHEEEEEEC | 14.64 | OGP | |
325 | Phosphorylation | HTFMGVVSLGSPSGE HHEEEEEECCCCCCC | 25.30 | 26657352 | |
325 | O-linked_Glycosylation | HTFMGVVSLGSPSGE HHEEEEEECCCCCCC | 25.30 | OGP | |
328 | O-linked_Glycosylation | MGVVSLGSPSGEVSH EEEEECCCCCCCCCC | 22.61 | OGP | |
328 | Phosphorylation | MGVVSLGSPSGEVSH EEEEECCCCCCCCCC | 22.61 | 21082442 | |
330 | O-linked_Glycosylation | VVSLGSPSGEVSHPR EEECCCCCCCCCCCC | 49.65 | OGP | |
330 | Phosphorylation | VVSLGSPSGEVSHPR EEECCCCCCCCCCCC | 49.65 | 23911959 | |
334 | O-linked_Glycosylation | GSPSGEVSHPRKTRT CCCCCCCCCCCCCCE | 24.38 | OGP | |
334 | Phosphorylation | GSPSGEVSHPRKTRT CCCCCCCCCCCCCCE | 24.38 | 21082442 | |
339 | Phosphorylation | EVSHPRKTRTVVQPS CCCCCCCCCEEECCC | 32.62 | 24505115 | |
339 | O-linked_Glycosylation | EVSHPRKTRTVVQPS CCCCCCCCCEEECCC | 32.62 | UniProtKB CARBOHYD | |
341 | Phosphorylation | SHPRKTRTVVQPSVG CCCCCCCEEECCCCC | 30.20 | 24505115 | |
341 | O-linked_Glycosylation | SHPRKTRTVVQPSVG CCCCCCCEEECCCCC | 30.20 | OGP | |
346 | O-linked_Glycosylation | TRTVVQPSVGAAAGP CCEEECCCCCHHCCC | 18.98 | 22171320 | |
346 | Phosphorylation | TRTVVQPSVGAAAGP CCEEECCCCCHHCCC | 18.98 | 24505115 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
135 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
138 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
319 | T | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
325 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
328 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
330 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXO2 | Q9UK22 | PMID:12140560 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FETUA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FETUA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PPP5_HUMAN | PPP5C | physical | 22939629 | |
POTEF_HUMAN | POTEF | physical | 26186194 | |
POTEF_HUMAN | POTEF | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-156; ASN-176 AND SER-346, STRUCTURE OFCARBOHYDRATES, AND MASS SPECTROMETRY. | |
"Enrichment of glycopeptides for glycan structure and attachment siteidentification."; Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.; Nat. Methods 6:809-811(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-156 AND ASN-176, STRUCTUREOF CARBOHYDRATES, AND MASS SPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-156, AND MASSSPECTROMETRY. | |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-156 AND ASN-176, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-156 AND ASN-176, AND MASSSPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-156, AND MASSSPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-176. | |
O-linked Glycosylation | |
Reference | PubMed |
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD."; Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.; Mol. Cell. Proteomics 0:0-0(2011). Cited for: GLYCOSYLATION AT ASN-156; ASN-176 AND SER-346, STRUCTURE OFCARBOHYDRATES, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134 AND SER-138, ANDMASS SPECTROMETRY. | |
"An initial characterization of the serum phosphoproteome."; Zhou W., Ross M.M., Tessitore A., Ornstein D., Vanmeter A.,Liotta L.A., Petricoin E.F. III; J. Proteome Res. 8:5523-5531(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328; SER-330 ANDSER-334, TISSUE SPECIFICITY, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND MASSSPECTROMETRY. | |
"Phosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein(human fetuin) in vivo."; Haglund A.C., Ek B., Ek P.; Biochem. J. 357:437-445(2001). Cited for: PARTIAL PROTEIN SEQUENCE, AND PHOSPHORYLATION AT SER-138 AND SER-330. |